Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: The 15-year Johns Hopkins experience

Urologic Clinics of North America

Volumn 28, Issue 3, 2001, Pages 555-565

  Han, Misop ^a   Partin, Alan W ^a   Pound, Charles R ^c   Epstein, Jonathan I ^a,b   Walsh, Patrick C ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER STAGING; CANCER SURVIVAL; HUMAN; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SCORING SYSTEM; SURGICAL ANATOMY;

EID: 0034817278     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70163-4     Document Type: Article

References (18)

1. 5-Year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer
2. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: Intermediate-term results
3. Prediction of progression following radical prostatectomy: A multivariate analysis of 721 men with long-term follow-up
4. Correlation of pathologic findings with progression after radical retropubic prostatectomy
5. Histologic grading and clinical staging of carcinoma of the prostate
6. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
7. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer
8. Serum PSA after anatomic radical prostatectomy: The Johns Hopkins experience after 10 years
9. Natural history of progression after PSA elevation following radical prostatectomy
10. Prostatespecific antigen after anatomic radical retropubic prostatectomy: Patterns of recurrence and cancer control
11. Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer
12. An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery
13. Prostate cancer is highly predictable: A prognostic equation based on all morphological variables in radical prostatectomy specimens
14. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy
15. The natural history of localized prostate cancer: A guide to therapy
16. Impotence following radical prostatectomy: Insight into etiology and prevention
17. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer